We are incredibly excited to launch our new ‘Biotech Due Diligence Services’ in collaboration with Veramed.
With this unique partnering of capabilities across translational medicine, clinical development and biostatistics, our combined team of experts is able to conduct data driven due diligence to ensure the value of any potential acquisition or partnership you are considering is appropriate.
We have created a bespoke due diligence framework which adapts our work to suit your needs and enables us to thoroughly interrogate the scientific and clinical merits of the assets in question. We will leave no stone unturned and seek to highlight additional opportunities for the assets along the way.